{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:23:51Z","timestamp":1775244231239,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.anndiagpath.2020.151503","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T06:13:10Z","timestamp":1584079990000},"page":"151503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Presence of tumor cells in the vagina during surgical treatment could be the source of vaginal recurrence in patients with endometrial carcinoma \u2014 A pilot prospective study"],"prefix":"10.1016","volume":"46","author":[{"given":"Simona","family":"Stolnicu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Terinte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolae","family":"Ioanid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvio","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2020.151503_bb0005","author":"Anon"},{"key":"10.1016\/j.anndiagpath.2020.151503_bb0010","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151503_bb0015","first-page":"1404","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial","volume":"355","author":"Creutzberg","year":"2000","journal-title":"PORTEC Study Group Post Operative Radiation Therapy in Endometrial Carcinoma Lancet"},{"key":"10.1016\/j.anndiagpath.2020.151503_bb0020","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.anndiagpath.2020.151503_bb0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Blake","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.anndiagpath.2020.151503_bb0030","author":"NCCN"},{"key":"10.1016\/j.anndiagpath.2020.151503_bb0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/PGP.0b013e31829c6757","article-title":"Risk factors for recurrence and prognosis of low-grade endometrial adenocarcinoma; vaginal versus other sites","volume":"33","author":"Moschiano","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151503_bb0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0360-3016(94)00399-6","article-title":"Brachytherapy-related complications for medically inoperable stage I endometrial carcinoma","volume":"31","author":"Chao","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.anndiagpath.2020.151503_bb0045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1055\/s-2008-1036247","article-title":"Afterloading short-term irradiation of inoperable uterine cancer","volume":"46","author":"Kucera","year":"1986","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.anndiagpath.2020.151503_bb0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0360-3016(00)00497-1","article-title":"The American brachytherapy society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix","volume":"48","author":"Nag","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.anndiagpath.2020.151503_bb0055","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.brachy.2015.06.002","article-title":"Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer","volume":"14","author":"Schwarz","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.anndiagpath.2020.151503_bb0060","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.anndiagpath.2020.151503_bb0065","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1200\/JCO.2013.48.8023","article-title":"Long-term outcomes after pelvic radiation for early-stage endometrial cancer","volume":"31","author":"Onsrud","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151503_bb0070","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5114\/jcb.2014.45493","article-title":"Acute complications following intracavitary high-dose-rate brachytherapy in uterine cancer","volume":"6","author":"Gupta","year":"2014","journal-title":"J Contemp Brachytherapy"},{"issue":"8","key":"10.1016\/j.anndiagpath.2020.151503_bb0075","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s12094-012-0974-0","article-title":"Three or four fractions per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma. The long-term results on vaginal relapses and toxicity","volume":"15","author":"Valduvieco","year":"2013","journal-title":"Clin Transl Oncol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2020.151503_bb0080","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12094-015-1463-z","article-title":"Vaginal-cuff control and toxicity results of a daily HDR brachytherapy schedule in endometrial cancer patients","volume":"18","author":"R\u00edos","year":"2016","journal-title":"Clin Transl Oncol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2020.151503_bb0085","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5114\/jcb.2018.79713","article-title":"Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results","volume":"10","author":"Delishaj","year":"2018","journal-title":"J Contemp Brachytherapy"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420300447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420300447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:31:41Z","timestamp":1761078701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913420300447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":17,"alternative-id":["S1092913420300447"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151503","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presence of tumor cells in the vagina during surgical treatment could be the source of vaginal recurrence in patients with endometrial carcinoma \u2014 A pilot prospective study","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151503","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151503"}}